{"id":223886,"date":"2026-08-31T12:28:20","date_gmt":"2026-08-31T06:58:20","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=223886"},"modified":"2026-08-31T12:28:20","modified_gmt":"2026-08-31T06:58:20","slug":"why-rubicon-research-limited-share-price-price-rise-2026-08-31","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-rubicon-research-limited-share-price-price-rise-2026-08-31\/","title":{"rendered":"RUBICON RESEARCH LIMITED (RUBICON) Share Price Rises 2.12% Today"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/rubicon\/rubicon-research-limited-share-price-today\">RUBICON RESEARCH LIMITED (RUBICON)<\/a> share price rose to Rs 1,844 today, up 2.12% from the previous close. Market cap was Rs 29,891.75 crore.<\/em><\/div>\n<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong> 31 August 2026 at 12:19:31 PM IST<\/p>\n<p style=\"margin-top:0!important;\">RUBICON Share Price moved higher today, with the stock rising 2.12% to Rs 1,844.00 from the previous close of Rs 1,805.80. The company\u2019s market capitalisation stood at Rs 29,891.75 crore, placing the move in the context of a sizeable listed healthcare name rather than a purely speculative counter. The day\u2019s range was Rs 1,782.25 to Rs 1,852.50, while the open was Rs 1,819.30, giving a clear picture of how RUBICON Share Price behaved through the session. The supplied data confirms the price event, but it does not establish a company-specific catalyst. For readers tracking RUBICON Stock News or RUBICON News Today, the most useful next checks are valuation, sector comparison and whether the move aligns with the company\u2019s broader financial profile on Univest. Because the move was measured rather than extreme, the session is best read as a positive price update supported by straightforward market data rather than a headline tied to a disclosed announcement.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-limited-share-price-price-rise-2026-08-31\/#RUBICON_Share_Price_Today_Price_Action_Analysis\" title=\"RUBICON Share Price Today: Price Action Analysis\">RUBICON Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-limited-share-price-price-rise-2026-08-31\/#RUBICON_RESEARCH_LIMITED_RUBICON_Fundamental_Analysis\" title=\"RUBICON RESEARCH LIMITED (RUBICON) Fundamental Analysis\">RUBICON RESEARCH LIMITED (RUBICON) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-limited-share-price-price-rise-2026-08-31\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-limited-share-price-price-rise-2026-08-31\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-limited-share-price-price-rise-2026-08-31\/#Why_Investors_Are_Watching_RUBICON\" title=\"Why Investors Are Watching RUBICON\">Why Investors Are Watching RUBICON<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-limited-share-price-price-rise-2026-08-31\/#About_RUBICON\" title=\"About RUBICON\">About RUBICON<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-limited-share-price-price-rise-2026-08-31\/#Track_RUBICON_Share_Price_on_Univest\" title=\"Track RUBICON Share Price on Univest\">Track RUBICON Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-limited-share-price-price-rise-2026-08-31\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-limited-share-price-price-rise-2026-08-31\/#Why_is_RUBICON_Share_Price_rising_today\" title=\"Why is RUBICON Share Price rising today?\">Why is RUBICON Share Price rising today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-limited-share-price-price-rise-2026-08-31\/#What_is_RUBICON_Share_Price_today\" title=\"What is RUBICON Share Price today?\">What is RUBICON Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-limited-share-price-price-rise-2026-08-31\/#What_is_the_market_capitalisation_of_RUBICON\" title=\"What is the market capitalisation of RUBICON?\">What is the market capitalisation of RUBICON?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-limited-share-price-price-rise-2026-08-31\/#Is_RUBICON_expensive_on_valuation\" title=\"Is RUBICON expensive on valuation?\">Is RUBICON expensive on valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-limited-share-price-price-rise-2026-08-31\/#How_do_RUBICONs_profitability_ratios_compare_with_the_sector\" title=\"How do RUBICON\u2019s profitability ratios compare with the sector?\">How do RUBICON\u2019s profitability ratios compare with the sector?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-limited-share-price-price-rise-2026-08-31\/#How_does_RUBICON_compare_with_peer_stocks\" title=\"How does RUBICON compare with peer stocks?\">How does RUBICON compare with peer stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-rubicon-research-limited-share-price-price-rise-2026-08-31\/#What_are_the_key_fundamentals_behind_RUBICON_Share_Price\" title=\"What are the key fundamentals behind RUBICON Share Price?\">What are the key fundamentals behind RUBICON Share Price?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"RUBICON_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>RUBICON Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,844<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,805.8<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 38.2 (+2.12%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,819.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,852.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,782.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3.41 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 29,891.75 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Large Cap<\/td>\n<\/tr>\n<\/table>\n<p>RUBICON RESEARCH LIMITED (RUBICON) rose to Rs 1,844 from the previous close of Rs 1,805.8, a move of Rs 38.2 or 2.12%. The stock opened at Rs 1,819.3, reached a high of Rs 1,852.5, recorded a low of Rs 1,782.25.<\/p>\n<p>RUBICON Share Price showed a clean upward bias through the session. After opening at Rs 1,819.30, the stock moved above the opening level and ultimately finished at Rs 1,844.00, which was also above the previous close of Rs 1,805.80. That sequence matters because it shows the stock held onto gains into the close rather than giving them back.<\/p>\n<p>The day\u2019s low of Rs 1,782.25 came below the previous close, so the stock did briefly trade in weaker territory. However, the recovery toward the upper end of the range suggests that buyers were able to absorb early softness. The high of Rs 1,852.50 remained close to the closing price, which indicates RUBICON Share Price spent much of the later part of trade near its stronger levels.<\/p>\n<p>Turnover stood at Rs 3.41 crore, which gives a basic sense of market activity for the day without adding any unsupported interpretation. The important point is not just that RUBICON Share Price rose, but that the close was near the day\u2019s high and clearly above the prior session\u2019s reference point. For an event-based update, that is the strongest factual signal available in the data.<\/p>\n<p>In practical terms, today\u2019s session shows a stock that opened slightly above the previous close, slipped to a lower intraday point, and then recovered enough to end with a 2.12% gain. That pattern is the core reason this price rise stands out in RUBICON Share Price Today coverage. It is also why the move should be viewed through the lens of price action first, then fundamentals and peers second.<\/p>\n<p>RUBICON Share Price closed at Rs 1,844.00 after adding Rs 38.20 on the day. The stock opened at Rs 1,819.30, moved between Rs 1,782.25 and Rs 1,852.50, and finished above the previous close of Rs 1,805.80. Turnover stood at Rs 3.41 crore. This confirms a same-day price rise in RUBICON Stock News without assigning a cause that the supplied data does not verify. For investors following RUBICON Share Price Today, the main factual takeaway is that the stock ended near the upper part of the day\u2019s range and above its prior close, which is the core event captured in today\u2019s share price rise.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"RUBICON_RESEARCH_LIMITED_RUBICON_Fundamental_Analysis\"><\/span><strong>RUBICON RESEARCH LIMITED (RUBICON) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 29,891.75 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">103.71x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">22.27x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.84%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">29.22%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 17.41<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 81.09<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.08%<\/td>\n<\/tr>\n<\/table>\n<p>RUBICON RESEARCH LIMITED (RUBICON) fundamental metrics show P\/E 103.71x, P\/B 22.27x, ROE 27.84%, ROCE 29.22%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>RUBICON RESEARCH LIMITED has a market capitalisation of Rs 29891.75 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 103.71x, P\/B at 22.27x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 27.84% and ROCE of 29.22%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 17.41, book value per share of Rs 81.09, dividend yield of 0.08%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P\/E of 31.21x, median ROE of 11.78%, median ROCE of 13.6%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">103.71x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.21x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.1x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.7x to 672.45x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">22.27x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.88x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.84%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.78%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">29.22%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.6%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 29,891.75 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 670.73 crore<\/td>\n<\/tr>\n<\/table>\n<p>RUBICON RESEARCH LIMITED (RUBICON) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>RUBICON RESEARCH LIMITED (RUBICON) has a P\/E ratio of 103.71x, which is above the benchmark median of 31.21x, a difference of +232.3%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>RUBICON RESEARCH LIMITED (RUBICON) has a ROE of 27.84%, which is above the benchmark median of 11.78%, a difference of +136.33%. RUBICON RESEARCH LIMITED (RUBICON) has a ROCE of 29.22%, which is above the benchmark median of 13.6%, a difference of +114.85%.<\/p>\n<p>Track stocks leading today through the <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,60,696.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">38.09<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.33<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi-s-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Divi&#39;s Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,46,062.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">84.12<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,91,515.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">87.81<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.34<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,18,403.7<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.24<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.39<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,14,554.33<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.99<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.26<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>RUBICON RESEARCH LIMITED (RUBICON) has a P\/E ratio of 103.71x compared with the displayed peer median of 38.09x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 27.84% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 29.22% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. RUBICON RESEARCH LIMITED (RUBICON) has a market capitalisation of Rs 29,891.75 crore. Among the 5 peers shown, 5 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_RUBICON\"><\/span><strong>Why Investors Are Watching RUBICON<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>RUBICON Share Price rose 2.12% today to Rs 1,844.00 after a previous close of Rs 1,805.80.<\/li>\n<li>The day\u2019s range was Rs 1,782.25 to Rs 1,852.50, and the open was Rs 1,819.30.<\/li>\n<li>Market capitalisation stood at Rs 29,891.75 crore, placing RUBICON in a large listed healthcare profile by market value.<\/li>\n<li>P\/E of 103.71 and P\/B of 22.27 show a premium valuation against the supplied healthcare benchmark and peer set.<\/li>\n<li>ROE of 27.84% and ROCE of 29.22% are above the supplied sector median and average figures.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_RUBICON\"><\/span><strong>About RUBICON<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>RUBICON RESEARCH LIMITED operates in the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. The supplied data does not break out product lines, revenue mix or segment details, so the most reliable company profile here is the listed classification itself and the financial footprint attached to it. With a market capitalisation of Rs 29,891.75 crore, RUBICON sits among higher-valued listed healthcare companies in India.<\/p>\n<p>For readers using Univest to review RUBICON Share Price, the key company context today is its combination of a premium valuation, strong profitability ratios and a position inside a broad pharmaceuticals universe of 203 companies. That makes RUBICON Share Price relevant not just as a one-day move, but also as a stock where price action needs to be read alongside fundamentals, sector benchmarks and peer comparisons. In Univest coverage, this is the kind of stock where RUBICON Company News, RUBICON Stock Performance and RUBICON Share Price Update are best understood together. The company summary remains intentionally concise because the supplied dataset is limited to listed market and financial metrics rather than operating detail.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_RUBICON_Share_Price_on_Univest\"><\/span><strong>Track RUBICON Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/rubicon\/rubicon-research-limited-share-price-today\">RUBICON RESEARCH LIMITED (RUBICON) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top-gainers lists and related market analysis.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_RUBICON_Share_Price_rising_today\"><\/span><strong>Why is RUBICON Share Price rising today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied data confirms a 2.12% rise in RUBICON Share Price to Rs 1,844.00, but it does not establish a company-specific catalyst. The session data only shows the move, range and turnover, not the reason.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_RUBICON_Share_Price_today\"><\/span><strong>What is RUBICON Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> RUBICON Share Price today is Rs 1,844.00, up Rs 38.20 from the previous close of Rs 1,805.80. The stock opened at Rs 1,819.30 and traded between Rs 1,782.25 and Rs 1,852.50 during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_RUBICON\"><\/span><strong>What is the market capitalisation of RUBICON?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> RUBICON\u2019s market capitalisation is Rs 29,891.75 crore. That places the company above the sector median and average market-cap figures in the supplied Pharmaceuticals &amp; Drugs benchmark, giving RUBICON Share Price strong size context.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_RUBICON_expensive_on_valuation\"><\/span><strong>Is RUBICON expensive on valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Based on the supplied numbers, RUBICON trades at a P\/E of 103.71 and a P\/B of 22.27, both above the sector benchmark and peer set. That means RUBICON Share Price appears premium on valuation measures.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_do_RUBICONs_profitability_ratios_compare_with_the_sector\"><\/span><strong>How do RUBICON\u2019s profitability ratios compare with the sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> RUBICON reports ROE of 27.84% and ROCE of 29.22%, both above the sector median and average supplied for Pharmaceuticals &amp; Drugs. Those figures give RUBICON Share Price a strong profitability context.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_RUBICON_compare_with_peer_stocks\"><\/span><strong>How does RUBICON compare with peer stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Among the supplied peers, RUBICON has the highest P\/E, P\/B, ROE and ROCE. Its market capitalisation is below Sun Pharma, Divi\u2019s Laboratories and Torrent Pharmaceuticals, but above Zydus Lifesciences and Cipla in the table.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_fundamentals_behind_RUBICON_Share_Price\"><\/span><strong>What are the key fundamentals behind RUBICON Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main fundamentals are EPS of Rs 17.41, book value of Rs 81.09, dividend yield of 0.08%, ROE of 27.84% and ROCE of 29.22%. These metrics provide a clear financial context for RUBICON Share Price.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>RUBICON RESEARCH LIMITED Share Price rises to Rs 1,844. marking a 2.12% rise today. Market cap stands at Rs 29,891.75 crore.<\/p>\n","protected":false},"author":29,"featured_media":223885,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-223886","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["223885"],"rank_math_title":["RUBICON Share Price Today: Price Rise and Sector Context"],"rank_math_description":["RUBICON Share Price rose 2.12% to Rs 1,844.00. Read today\u2019s price action, valuation, sector comparison and company context."],"rank_math_focus_keyword":["RUBICON Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/RUBICON_RESEARCH_LIMITED_RUBICON_Share_Price_Rises_212_Today_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/223886","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=223886"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/223886\/revisions"}],"predecessor-version":[{"id":223887,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/223886\/revisions\/223887"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/223885"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=223886"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=223886"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=223886"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}